UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping

Oct.04.2024
UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping
A UK study shows that there are 5.1 million e-cigarette users among people aged 16 and over, with the usage rate highest among the 16-24 age group at 15.8%. Over 1 million non-regular smokers have started using e-cigarettes, with usage increasing sevenfold over the past three years.

According to a recent report by The Guardian, research data shows that one in every ten people aged 16 and above in the UK is using e-cigarettes. The number of non-regular smokers in the UK who have started using e-cigarettes has increased sevenfold in three years, reaching 1 million. This has raised concerns among health experts.


Before 2021, the usage of e-cigarettes among non-regular adult smokers remained stable, with approximately 1 in 200 people, or about 133,000 individuals, using e-cigarettes. However, a study published in The Lancet Public Health indicates that by 2024, this proportion is projected to increase sharply to 1 in every 28 people, equating to 1.006 million individuals.


Data released this week by the Office for National Statistics in the UK reveals that there are a total of 5.1 million e-cigarette users aged 16 and over in the country. The age group with the highest e-cigarette usage rate is 16 to 24-year-olds, with a rate of 15.8%.


The study also found that the majority of e-cigarette users who had never smoked regularly are using e-cigarettes on a daily basis and for longer periods of time. This sharp increase is mainly driven by young people, with research showing that 14% of non-regular smokers aged 18 to 24 in the UK are now using e-cigarettes.


Researchers warn that the UK government's plans to ban disposable e-cigarettes may not fully address the issue, as some brands have already introduced reusable products. Experts suggest that reducing the appeal of e-cigarette products may require stricter regulations and laws.


Professor Jamie Brown from the Institute of Epidemiology and Health Care at University College London (UCL) believes that although measures to ban disposable e-cigarettes may not be enough to solve the problem, stricter regulations on the appearance, packaging, and marketing of products could be introduced. These measures are unlikely to reduce the effectiveness of e-cigarettes in smoking cessation. He points out that by 2023, the overall prevalence of e-cigarettes seems to be stabilizing, which may provide a reasonable basis for implementing these measures and assessing their effectiveness.


The study analyzed survey data from 153,073 adults in the UK between 2016 and 2024, of which 94,107 had never smoked regularly. The data showed that the proportion of non-smokers who used e-cigarettes increased from 0.5% in 2016-2020 to 3.5% by April 2024, surpassing 1 million people, with over half of them aged between 18 and 24.


Researchers also found that in recent years, the group of people who smoke irregularly tends to be younger, with an increase in the proportion of women. They are more likely to use disposable devices and high-concentration nicotine e-cigarette liquid, and mainly purchase products in supermarkets or convenience stores.


In a statement released by the Department of Health and Social Welfare in the UK, the department emphasized that although e-cigarettes can effectively help adults quit smoking, children and non-smoking adults should not use e-cigarettes. The department stated that the Tobacco and E-cigarette Act will protect future generations from the harms of tobacco and nicotine, save countless lives, and alleviate pressure on the national healthcare system.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches
Alaska AG warns 1,500+ retailers to stop selling unauthorized vapes and nicotine pouches
Alaska’s attorney general has sent warning letters to more than 1,500 retailers and distributors, cautioning them against selling tobacco products — including e-cigarettes and oral nicotine pouches — that lack U.S. Food and Drug Administration authorization.
Mar.06 by 2FIRSTS.ai
Belarus Official Says Full Vape Ban Is Not Advisable Due to Supply Risks From Russia
Belarus Official Says Full Vape Ban Is Not Advisable Due to Supply Risks From Russia
A Belarusian Interior Ministry official said on March 18 at a press conference on preventing dependence on electronic smoking systems that a full ban on vapes is not appropriate in Belarus at this stage.
Mar.19 by 2FIRSTS.ai
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
North Carolina hemp provider JLT Imports Inc. has filed suit in California federal court seeking cancellation of the “Lost Mary” vape trademark held by Chinese company Imiracle (HK) Ltd.
Mar.30 by 2FIRSTS.ai
Reuters: More “Made in America” Vape Products Appear in the U.S. Amid Trump Tariffs and Crackdown
Reuters: More “Made in America” Vape Products Appear in the U.S. Amid Trump Tariffs and Crackdown
According to Reuters, the U.S. vaping market has recently seen an increase in products marketed as “Made in America” amid the Trump administration’s stronger enforcement against unauthorized vape brands and increased trade tariff pressure on Chinese goods. Since October 2025, at least eight new vape brands highlighting American credentials have entered the U.S. market, and none of them has authorization for sale. Brands mentioned by Reuters include Maxus Star and OneTank.
Apr.08
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24